Munar Pharma

Munar Pharma Debt/EBITDA

Delisted

The Total Debt to EBITDA Ratio of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -1.07. In the previous year, Total Debt to EBITDA Ratio was -0.05 — a change of 2,204.68% (lower).

Debt/EBITDA

-1.07

YoY

2,204.68%

Last updated:

Total Debt to EBITDA Ratio of Munar Pharma is 2024 -1.07 . Total Debt to EBITDA Ratio of Munar Pharma was 2023 -0.05 . It decreases by 2,204.68% lower compared to the previous year.

The Munar Pharma Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
-0.80 PLN
Jan 1, 2018
-0.02 PLN
Jan 1, 2019
-10.72 PLN
Jan 1, 2020
-0.05 PLN
Jan 1, 2021
-0.02 PLN
Jan 1, 2022
0.00 PLN
Jan 1, 2023
-0.05 PLN
Jan 1, 2024
-1.07 PLN
The Munar Pharma Debt/EBITDA history
YEARDebt/EBITDAYoY
-1.07+2,204.68%
-0.05—
0.00-100.00%
-0.02-65.65%
-0.05-99.54%
-10.72+47,115.86%
-0.02-97.17%
-0.80-112.76%
6.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

Total Debt to EBITDA Ratio of Munar Pharma is -1.07 in 2024.

Total Debt to EBITDA Ratio of Munar Pharma changed from -0.05 to -1.07, representing a 2,204.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Munar Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Munar Pharma

All Key Metrics — Munar Pharma